| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARDELYX, INC. | Director | Stock Option (Right to Buy) | 40.2K | $93.4K | $2.32 | Jun 14, 2024 | Direct |
| Akari Therapeutics Plc | Director | Stock Option (Right to Buy) | 5M | Sep 17, 2024 | Direct | ||
| Nuvation Bio Inc. | Director | Stock Option (Right to Buy) | 201K | Sep 3, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | Sep 17, 2024 | 1 | $0 | 4 | Sep 18, 2024 | Director |
| AKTX | Akari Therapeutics Plc | Sep 17, 2024 | 0 | $0 | 3 | Sep 18, 2024 | Director |
| NUVB | Nuvation Bio Inc. | Sep 3, 2024 | 1 | $0 | 4 | Sep 5, 2024 | Director |
| ARDX | ARDELYX, INC. | Jun 14, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
| ARDX | ARDELYX, INC. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| NUVB | Nuvation Bio Inc. | May 15, 2023 | 1 | $0 | 4 | May 17, 2023 | Director |
| ARDX | ARDELYX, INC. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| NUVB | Nuvation Bio Inc. | May 16, 2022 | 1 | $0 | 4/A | Jun 28, 2022 | Director |
| NUVB | Nuvation Bio Inc. | Oct 29, 2021 | 1 | $0 | 4 | Nov 2, 2021 | Director |
| ARDX | ARDELYX, INC. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |